Skip to content

Sofie Odent

Active
Private limited companyfounded 2019active for 7 yearsGrote Molenweg 74, 3020 Herent, BelgiumKBO/BCE: BE 0729.970.926
Summary

Sofie Odent has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €100 and a net result of €307,964. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 5% of 20,643 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
≈ €630,000turnover 2025, estimated
Equity
€100
Profit
€307,964
Turnover estimated from the gross margin
Financial health
92 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts 94 days early1 of 2 deeds summarised
Why 92raises riskEquity €100 (0.1% of total assets)lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 0.93, cash €122,391Size: total assets €145,819Show the evidence

Checked score

Score 2025
92 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 35% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Average
Solvency 25=
equity 0.1% of total assets
Liquidity 50=
short-term debt 99.9% · cash 83.9%
Profitability 100=
return on assets 211.2%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,138 companies, NACE 86, micro)
Last 24 months 11-2024: 0.1%highest value 12-2024: < 0.1%▼ -0.1 percentage points vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026lowest value 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 4% on solvency, 20% on liquidity, 80% on profitability and 37% on growth.

The bankruptcy probability was computed on 28-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 0.93, cash €122,391
NBB · annual accounts
lowers risk · Size: total assets €145,819
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Equity €100 (0.1% of total assets)
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 5% of 20643 sector peers (2025).
NBB · sector comparison
Position among 20643 sector peers
Solvency
better than 5%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-04-2026, 94 days ahead of the deadline.
NBB · 7 filings
Deviation from the deadline
2025
94 days early
2024
157 days early
2023
110 days early
2022
34 days early
2021
31 days early
2020
29 days early
2019
49 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 72 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 28 April (5 of the last 5 filed years within 63 days of that day).
Companies Code · seven months
Where today falls in the filing period
29-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Highest result from 2019 to 2025net €307,964 ▲22.9%
  3. Annual accounts filedfinancial year 2024 · micro…

Financials · financial year 2025, micro format

Turnover
€47,844
EBIT margin
0.0%
Net result
€307,964▲ 22.9%
2024 · €250,585
Working capital
-€9,897▲ 20.5%
2024 · -€12,451
Trend over the years

2021 to 2025, 5 financial years 2019 to 2025, 7 financial years

The operating result has risen four years in a row; 2025 is 24% above 2024 and is the highest result in the available series.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€404,287 2025 Net result€307,964 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line2019202020212022202320242025
Turnover€47,844
Operating result€99,865-€11,721▼ 88.3%€1▼ 100.0%€37,575▲ 48,173×€120,245▲ 220%€326,827▲ 172%€404,287▲ 23.7%
Net result€83,047-€8,693below the sector's middle half▼ 89.5%-€1,281below the sector's middle half€28,341within the sector's middle half€91,371within the sector's middle half▲ 222%€250,585above the sector's middle half▲ 174%€307,964above the sector's middle half▲ 22.9%
EBIT margin0.0%
Equity€63,047-€71,740within the sector's middle half▲ 13.8%€70,459within the sector's middle half▼ 1.8%€100below the sector's middle half▼ 99.9%€100below the sector's middle half=€100below the sector's middle half=€100below the sector's middle half=
Total assets€102,743-€76,768below the sector's middle half▼ 25.3%€72,905below the sector's middle half▼ 5.0%€85,039below the sector's middle half▲ 16.6%€179,621within the sector's middle half▲ 111%€198,204within the sector's middle half▲ 10.3%€145,819within the sector's middle half▼ 26.4%
Debt€39,696-€5,027▼ 87.3%€2,446▼ 51.3%€84,939▲ 35×€179,521▲ 111%€198,104▲ 10.4%€145,719▼ 26.4%
Working capital€61,906-€71,055within the sector's middle half▲ 14.8%€70,231within the sector's middle half▼ 1.2%€100below the sector's middle half▼ 99.9%-€6,015below the sector's middle half-€12,451below the sector's middle half▼ 107%-€9,897below the sector's middle half▲ 20.5%
Solvency61.4%-93.5%above the sector's middle half▲ 32.1pp96.6%above the sector's middle half▲ 3.2pp0.1%below the sector's middle half▼ 96.5pp0.1%below the sector's middle half▼ 0.1pp0.1%below the sector's middle half=0.1%below the sector's middle half=
Current ratio2.56-15.13above the sector's middle half▲ 12.5729.71above the sector's middle half▲ 14.581.00below the sector's middle half▼ 28.710.97below the sector's middle half▼ 0.030.94below the sector's middle half▼ 0.030.93below the sector's middle half▼ 0.01
Return on assets (ROA)80.8%-11.3%within the sector's middle half▼ 69.5pp-1.8%below the sector's middle half▼ 13.1pp33.3%above the sector's middle half▲ 35.1pp50.9%above the sector's middle half▲ 17.5pp126.4%above the sector's middle half▲ 75.6pp211.2%above the sector's middle half▲ 84.8pp
above within below the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €145,819
Fixed assets €9,997 ▼ 20.3%
Current assets €135,822 ▼ 26.8%
Equity and liabilities €145,819
Equity €100 =
Debt €145,719 ▼ 26.4%
Debt's share of the balance-sheet total stays at 99.9%.
Key figures and ratios
2025 value · change against 2024
EBITDA
€409,090▲
2024 · €329,755
Cash flow
€312,767▲
2024 · €253,513
Interest coverage
over 100
2024 · over 100
Debt ≤ 1 year
€145,719▼
2024 · €198,104
Income taxes
€98,118▲
2024 · €79,019
Equity ratios withheld: equity of €100 is too small for a meaningful ratio.
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 2,153 companies that looked in July 2024 the way this one looks now, 1.7% went bankrupt within 24 months and 96.1% are still going.

  • Micro
  • 5 to 10 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more
1.7% went bankrupt
2.2% stopped otherwise
96.1% still going

For this company itself Checked computes a lower bankruptcy probability: < 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 2,153 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 32 lines
Balance sheet Code20242025
Assets
Total assets20/58€198,204€145,819▼
Fixed assets21/28€12,551€9,997▼
Tangible fixed assets22/27€12,551€9,997▼
Furniture and vehicles24€12,551€9,997▼
Current assets29/58€185,653€135,822▼
Amounts receivable within one year40/41€16,308€9,305▼
Other amounts receivable41€16,308€9,305▼
Cash at bank and in hand54/58€167,546€122,391▼
Deferred charges and accrued income490/1€1,799€4,126▲
Equity and liabilities
Total equity and liabilities10/49€198,204€145,819▼
Equity10/15€100€100=
Contributions10/11€100€100=
Amounts payable17/49€198,104€145,719▼
Amounts payable within one year42/48€198,104€145,719▼
Trade debts44€2,671€3,307▲
Suppliers440/4€2,671€3,307▲
Other amounts payable47/48€195,433€142,412▼
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2,928€4,803▲
Other operating charges640/8€1,051€1,043▼
Gross operating margin9900€330,806€410,133▲
Operating profit (loss)9901€326,827€404,287▲
Financial income75/76B€2,870€1,841▼
Recurring financial income75€2,870€1,841▼
Financial charges65/66B€94€46▼
Recurring financial charges65€94€46▼
Profit (loss) for the period before taxes9903€329,603€406,082▲
Income taxes67/77€79,019€98,118▲
Profit (loss) for the period9904€250,585€307,964▲
Profit (loss) for the period to be appropriated9905€250,585€307,964▲
Appropriation of the result
Profit (loss) to be appropriated9906€250,585€307,964▲
Profit to be distributed694/7€250,585€307,964▲
Return on contributions (dividend)694€250,585€307,964▲

The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2019202020212022202320242025Change
Turnover70--€47,844-----
Goods, raw materials, services and sundry goods60/61--€51,715-----
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€228€457€457€228€127€2,928€4,803▲ 64.0%
Other operating charges640/8--€500€1,272€964€1,051€1,043▼ 0.7%
Gross operating margin9900€100,389€13,325€958€39,075€121,336€330,806€410,133▲ 24.0%
Operating profit (loss)9901€99,865€11,721€1€37,575€120,245€326,827€404,287▲ 23.7%
Financial income75/76B---€72-€2,870€1,841▼ 35.9%
Recurring financial income75---€72-€2,870€1,841▼ 35.9%
Financial charges65/66B--€37€315€2,582€94€46▼ 50.4%
Recurring financial charges65€25€60€37€315€2,582€94€46▼ 50.4%
Profit (loss) for the period before taxes9903€99,840€11,661-€36€37,332€117,663€329,603€406,082▲ 23.2%
Income taxes67/77€16,793€2,968€1,245€8,991€26,292€79,019€98,118▲ 24.2%
Profit (loss) for the period9904€83,047€8,693-€1,281€28,341€91,371€250,585€307,964▲ 22.9%
Profit (loss) for the period to be appropriated9905€83,047€8,693-€1,281€28,341€91,371€250,585€307,964▲ 22.9%
Line2019202020212022202320242025Change
Assets
Total assets20/58€102,743€76,768€72,905€85,039€179,621€198,204€145,819▼ 26.4%
Fixed assets21/28€1,142€685€228-€6,115€12,551€9,997▼ 20.3%
Tangible fixed assets22/27€1,142€685€228-€6,115€12,551€9,997▼ 20.3%
Furniture and vehicles24--€228-€6,115€12,551€9,997▼ 20.3%
Current assets29/58€101,601€76,083€72,677€85,039€173,506€185,653€135,822▼ 26.8%
Amounts receivable within one year40/41-€803€28,840€66,421€22,307€16,308€9,305▼ 42.9%
Other amounts receivable41--€28,840€66,421€22,307€16,308€9,305▼ 42.9%
Current investments50/53----€50,000---
Cash at bank and in hand54/58€92,398€72,566€40,578€17,057€88,968€167,546€122,391▼ 27.0%
Deferred charges and accrued income490/1--€3,259€1,561€12,231€1,799€4,126▲ 129%
Equity and liabilities
Total equity and liabilities10/49€102,743€76,768€72,905€85,039€179,621€198,204€145,819▼ 26.4%
Equity10/15€63,047€71,740€70,459€100€100€100€100=
Contributions10/11€100-€100€100€100€100€100=
Reserves13€62,947€71,640€70,359-----
Distributable reserves133--€70,359-----
Amounts payable17/49€39,696€5,027€2,446€84,939€179,521€198,104€145,719▼ 26.4%
Amounts payable within one year42/48€39,696€5,027€2,446€84,939€179,521€198,104€145,719▼ 26.4%
Trade debts44€84-€320€1,238€192€2,671€3,307▲ 23.8%
Suppliers440/4--€320€1,238€192€2,671€3,307▲ 23.8%
Taxes, remuneration and social security45--€1,545-----
Taxes450/3--€1,545-----
Other amounts payable47/48--€581€83,701€179,329€195,433€142,412▼ 27.1%
Line2019202020212022202320242025Change
Profit (loss) for the period9904€83,047€8,693-€1,281€28,341€91,371€250,585€307,964▲ 22.9%
+ Depreciation and write-downs630€228€457€457€228€127€2,928€4,803▲ 64.0%
Operating cash flow (approximation)€83,276€9,150-€824€28,570€91,497€253,513€312,767▲ 23.4%
Investment in fixed assets (approximation)-€0€0---€9,364-€2,249▲ 76.0%
Change in cash--€19,833-€31,988-€23,521€71,911€78,578-€45,155-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (7)
Financial year Type Filed Reference
31-12-2025 micro format 28-04-2026 2026-00090111
31-12-2024 micro format 24-02-2025 2025-00038202
31-12-2023 micro format 12-04-2024 2024-00061806
31-12-2022 micro format 27-06-2023 2023-00166912
31-12-2021 micro format 30-06-2022 2022-20130866
31-12-2020 micro format 02-07-2021 2021-31900194
31-12-2019 micro format 12-06-2020 2020-17400527

Similar companies · same sector, comparable size

Of the 16,579 active companies whose main activity is specialist medical practice (NACE 86220), figures are known for 8,122. 99 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
No directors read yet: 1 of 2 Gazette acts processed. See the directors and other office holders in the KBO →

Owners and capital

Owners

No owners or capital events in the accounts and acts we read.

History

Sofie Odent was incorporated on 9 July 2019 as a private limited company.1 The registered office was moved to Herent in 2022.2 Total assets rose from €102,743 in 2019 to €145,819 in 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 17-11-2022
  3. 3National Bank, annual accounts 2019 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
28-04
NBB filing Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial Highest result from 2019 to 2025net €307,964 ▲22.9%
Operating result €404,287, net result €307,964, both a record.
24-02
NBB filing Annual accounts filed
financial year 2024 · micro format
2024
12-04
NBB filing Annual accounts filed
financial year 2023 · micro format
2023
27-06
NBB filing Annual accounts filed
financial year 2022 · micro format
2022
31-12
Financial Back to profitnet €28,341
Net result €28,341 after one loss-making year.
17-11
Gazette deed Registered office
Registered-office move · Director in office3 facts ▸
  • General meeting, 01-10-2022
  • Registered-office move, Grote Molenweg 74 te 3020 Herent
  • Director in office, Sofie Odent (director)
30-06
NBB filing Annual accounts filed
financial year 2021 · micro format
2021
31-12
Financial Weakest financial yearnet -€1,281
Net result drops to -€1,281, the lowest in the series; recovery starts the following year.
02-07
NBB filing Annual accounts filed
financial year 2020 · micro format
2020
31-12
Financial Liquidity more than 5 timescurrent ratio 15.13
Current ratio from 2.56 to 15.13; short-term debt falls from €39,696 to €5,027.
12-06
NBB filing Annual accounts filed
financial year 2019 · micro format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
1 of 2 deeds read
About the unread acts

Of the 2 Belgian Official Gazette deeds we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded09-07-2019
Financial year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
77225Rental and leasing activities
77330Rental and leasing activities
86995Nutrition and dietetics services
E-invoicing
Reachable via Peppol
Peppol ID 0208:0729970926
Also 9925:BE0729970926
Registered 25-11-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 29 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Herent · 1 establishment unit since 2019
registered office establishment The establishment unit on the map
Ground area
1,070 m²
Building footprint
142 m²
Building volume
718 m³
Parcel 24423I0102/00L000, Flanders · tallest building 8.8 m. Linked by address, not a title deed.
2 companies at this address See who is registered here
1 establishment unit
Grote Molenweg 74, 3020 Herent
Specialist medical practice
since 2019unit no. 2.291.340.433
1 parcel
Flanders 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
24423I0102/00L000 Flanders 1,070 m² 1 · 142 m² 8.8 m · 2
How the parcels are linked
Good to know
The parcel matches the address exactly.